teaser
In the past 20 years concurrent chemoradiotherapy has gained popularity over induction chemotherapy (ICT). Positive trial results with docetaxel prompt the conclusion that ICT must be revisited.
Published on 1 November 2007
The role of docetaxel (Taxotere) in head and neck squamous cell carcinoma (HNSCC) management
Most read
1
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
